Image
InterMed Resources and UroViu Corp Announce Agreement With HealthTrust Purchasing Group
10. November 2022 09:00 ET | UroViu Corp
LOS ALTOS, Calif., Nov. 10, 2022 (GLOBE NEWSWIRE) --  InterMed Resources Tennessee and UroViu Corp, a company that develops and commercializes highly portable single-use endoscopy platforms,...
insightSLICE.png
Phoropters Market Sales are Expected to Witness Steady Growth to Reach US$ 235 million by 2031
25. Juni 2021 09:30 ET | insightSLICE
PUNE, India, June 25, 2021 (GLOBE NEWSWIRE) -- The Global Phoropters Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research...
Clover_Logo_Green_RGB.jpg
Clover Health, Mass. General, and ACP Decisions Research Team Secures Grant from National Institute of Health for Innovative Approach to Advance Care Planning
04. März 2021 16:05 ET | Clover Health Investments, Corp.
Five-year study will deploy technology to augment medical care for vulnerable patients with life-limiting illnessesSuccessful study will provide evidence that video decision aid improves advance care...
insightSLICE.png
Orphan Drugs Market Global Sales Are Expected To Reach US$ 413.36 Billion by 2030, as stated by insightSLICE
02. März 2021 09:54 ET | insightSLICE
PUNE, India, March 02, 2021 (GLOBE NEWSWIRE) -- The Global Orphan Drugs Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies, research...
insightSLICE.png
Herbal Medicine Market Global Sales Are Expected To Reach US$ 550 Billion by 2030, as stated by insightSLICE
16. Februar 2021 07:49 ET | insightSLICE
PUNE, India , Feb. 16, 2021 (GLOBE NEWSWIRE) -- The Global Herbal Medicine Market Share, Trends, Analysis and Forecasts, 2020-2030 provides insights on key developments, business strategies,...
UPM:n ensimmäinen kl
UPM:n ensimmäinen kliininen tuote myyntiin – FibDex® -haavasidos terveydenhuollon ammattilaisille
20. August 2020 03:00 ET | UPM-Kymmene Oyj
(UPM, Helsinki, 20.8.2020 klo 10:00 EET) UPM Biomedicalsin nanoselluloosasta valmistaman FibDex® -haavanhoitosidoksen kaupallistaminen ottaa merkittävän askeleen, kun sairaalatarvikkeiden johtaviin...
UPM brings its first
UPM brings its first clinical product to market – FibDex® wound dressing
20. August 2020 03:00 ET | UPM-Kymmene Corporation
(UPM, Helsinki, 20.8.2020 at 10:00 EET) FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device...